This inventor holds 10 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignees: Novartis Ag, Astex Therapeutics Limited. Active years: 2011-2018.
Company Filing History:
10 out of 3,974 
2 out of 126 
Years Active: 2011-2018
Title: Young Shin Cho: Innovator in Pharmaceutical Chemistry
Introduction
Young Shin Cho is a prominent inventor based in Cambridge, MA, known for his significant contributions to pharmaceutical chemistry. With a total of 10 patents to his name, he has made remarkable strides in the field of drug development, particularly in the treatment of diseases associated with mutant IDH proteins.
Latest Patents
Among his latest innovations are the patents for 3-pyrimidin-4-yl-oxazolidin-2-ones, which serve as inhibitors of mutant IDH. These inventions are directed to a specific formula, or a pharmaceutically acceptable salt thereof, wherein various substituents are defined. The patents also encompass compositions containing this compound and its application in inhibiting mutant IDH proteins that exhibit neomorphic activity. Furthermore, these compounds are intended for use in treating diseases or disorders linked to such mutant IDH proteins, including cell-proliferation disorders like cancer.
Career Highlights
Throughout his career, Young Shin Cho has worked with notable companies such as Novartis AG and Astex Therapeutics Limited. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.
Collaborations
Young Shin Cho has collaborated with esteemed colleagues, including Julian Roy Levell and Gang Liu, who have contributed to his research endeavors.
Conclusion
Young Shin Cho's innovative work in pharmaceutical chemistry, particularly in the development of inhibitors for mutant IDH proteins, showcases his dedication to advancing medical science. His contributions continue to have a significant impact on the treatment of serious diseases.